Double-Trouble: Atherosclerotic Risk Factors and Congenital Heart Disease

Justin P Zachariah1

  • 1Section of Pediatric Cardiology, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, 77030, USA. justin.zachariah@bcm.edu.

PubMed

Insights

Youth with congenital heart disease (CHD) face higher risks of atherosclerotic cardiovascular disease (ASCVD). Early management of obesity, dyslipidemia, and hypertension is crucial for improving long-term health outcomes in these vulnerable patients.

Area of Science:

  • Cardiology
  • Pediatrics
  • Preventive Medicine

Background:

  • Youth with congenital heart disease (CHD) are at increased risk for atherosclerotic cardiovascular disease (ASCVD) due to genetic and acquired risk factors.
  • Successful management of CHD necessitates addressing ASCVD risk factors to enhance patient longevity and outcomes.

Purpose of the Study:

  • To review guidelines for evaluating and managing obesity, dyslipidemia, and hypertension in youth under 18.
  • To highlight the specific vulnerabilities of CHD patients, particularly those with a history of cardiac surgery and residual disease.

Main Methods:

  • Review of current clinical guidelines for ASCVD risk factor management in pediatric CHD patients.
  • Focus on lifestyle, pharmacologic, and surgical interventions tailored to CHD survivors.

Main Results:

  • Obesity, dyslipidemia, and hypertension are highly prevalent ASCVD risk factors in youth with CHD.
  • Targeting these risk factors is essential to prevent ASCVD morbidity and mortality in CHD survivors.
  • Regular assessment of global risk factors, lifestyle counseling, and timely pharmacotherapy/surgery are recommended.

Conclusions:

  • Clinicians must proactively manage ASCVD risk factors in CHD patients to improve long-term health.
  • Future research should focus on interventions to optimize risk factor identification and treatment in this population.
  • Integrating comprehensive risk factor assessment and intervention into routine care is vital for CHD survivors.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
33
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
13
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
24
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
18